Bayesian Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,510
| Closed | -$1.3M | – | 841 |
|
|
2024
Q1 | $1.3M | Buy |
2,510
+1,561
| +164% | +$809K | 0.12% | 231 |
|
|
2023
Q4 | $448K | Buy |
+949
| New | +$448K | 0.05% | 409 |
|
|
2023
Q1 | – | Sell |
-2,584
| Closed | -$1.33M | – | 878 |
|
|
2022
Q4 | $1.33M | Buy |
+2,584
| New | +$1.33M | 0.19% | 124 |
|
|
2022
Q3 | – | Sell |
-1,762
| Closed | -$850K | – | 783 |
|
|
2022
Q2 | $850K | Buy |
+1,762
| New | +$850K | 0.16% | 189 |
|
|
2021
Q1 | – | Sell |
-3,148
| Closed | -$1.01M | – | 578 |
|
|
2020
Q4 | $1.01M | Buy |
3,148
+2,146
| +214% | +$689K | 0.26% | 101 |
|
|
2020
Q3 | $269K | Buy |
+1,002
| New | +$269K | 0.07% | 372 |
|
|
2019
Q3 | – | Sell |
-6,261
| Closed | -$1.77M | – | 563 |
|
|
2019
Q2 | $1.77M | Sell |
6,261
-2,000
| -24% | -$564K | 0.37% | 75 |
|
|
2019
Q1 | $2.37M | Buy |
8,261
+6,697
| +428% | +$1.92M | 0.46% | 54 |
|
|
2018
Q4 | $411K | Sell |
1,564
-1,171
| -43% | -$308K | 0.08% | 328 |
|
|
2018
Q3 | $750K | Sell |
2,735
-9,165
| -77% | -$2.51M | 0.12% | 238 |
|
|
2018
Q2 | $2.83M | Buy |
11,900
+7,700
| +183% | +$1.83M | 0.64% | 22 |
|
|
2018
Q1 | $923K | Sell |
4,200
-4,010
| -49% | -$881K | 0.23% | 136 |
|
|
2017
Q4 | $1.85M | Buy |
+8,210
| New | +$1.85M | 0.38% | 60 |
|
|
2017
Q3 | – | Sell |
-2,474
| Closed | -$465K | – | 527 |
|
|
2017
Q2 | $465K | Buy |
+2,474
| New | +$465K | 0.17% | 198 |
|